Posted in | News

Noble Prize Winner Joins Editorial Board of Journal Nanotechnology Progress International

The Noble Prize Winner in Medicine 2007, Dr Mario Capecchi has accepted to join the honorary editorial board of Journal Nanotechnology Progress International (JONPI). Dr. Capecchi is currently a Professor at University of Utah Howard Hughes Medical Institute.

He won the Nobel Prize in Medicine in 2007 with Drs Smithies and Evan for his groundbreaking research discovery of targeted mutation in mice paving way for a lot of innovative crucial applications in preventive medicine and cures of challenging diseases including tumor, cancer, etc.

Dr. Capecchi studied at Harvard and later became a professor there before his current position at Utah. Other outstanding numerous awards of Dr. Capecchi include Bristol Myers Squibb distinguished achievement in neuroscience, Gairdner Foundation International Achievement in Medical Sciences, Alfred Sloan prize of General Motor Cancer Research Foundation, Kyoto Prize in basic sciences, etc. He is a member of the National Academy of Sciences.

Please join me to welcome Dr. Capecchi to JONPI editorial board. Journal Nanotechnology Progress International (JONPI) is the #1 nano journal. Details about JONPI can be found at www.Fonai.org. Manuscripts continue to be actively accepted.

Focus Nanotechnology Africa Inc. (FONAI), is a not-for-profit and tax exempted under Section 501(c) (3) of the IRS code. It is for scientific and educational purpose in the USA, Africa and the Caribbean.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.